Frankly, it's your choice not to tell us they told you they've been through, but that doesn't matter. What matters is what they plan for the future, and from what I've seen, unless they open up on what they're doing, it will be like the past.

They need to speak with investors, not the privately held conferences, but conferences where they webcast what they're saying. They need to show their planned trials in clinical trials, where they don't leave questions about what they're planning, because it's contained in the database. They need to talk to investors when they issue quarterly results, and take questions from any analysts they can attract to take an interest in what they're doing. In short, they need to do more to attract investors.

I'm sorry, but two letters a year just aren't hacking it.

Gary